Cipla Q1 Results
- BSE: 500087
- NSE: CIPLA
- ISIN: INE059A01026
- Sector: Biotechnology & Drugs
BSE
1,331.70
2.15 (0.16%)
2.15 (0.16%)Volume19.47 K
Updated: Fri 13 Feb, 2026 | 15:29:58
NSE
1,3311.00 (0.08%)
1.00 (0.08%)Volume1.19 M
Updated: Fri 13 Feb, 2026 | 15:25:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Cipla Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5,432.05 | 5,500.83 | -1.25% | 5,224.82 | 3.97% |
| Depreciation/ Amortization | 252.72 | 308.73 | -18.14% | 246.68 | 2.45% |
| Operating Income | 1,525.42 | 1,228.86 | 24.13% | 1,469.12 | 3.83% |
| Net Income | 1,297.62 | 1,221.84 | 6.20% | 1,177.64 | 10.19% |
| Other Operating Expenses Total | 1,696.32 | 1,769.98 | -4.16% | 1,591.03 | 6.62% |
| Net Income Before Taxes | 1,769.93 | 1,504.30 | 17.66% | 1,611.36 | 9.84% |
| Total Revenue | 6,957.47 | 6,729.69 | 3.38% | 6,693.94 | 3.94% |
| Selling/ General/ Admin Expenses Total | 1,312.30 | 1,233.10 | 6.42% | 1,194.23 | 9.89% |
| Diluted Normalized EPS | 16.06 | 15.12 | 6.23% | 14.57 | 10.23% |